Zobrazeno 1 - 10
of 345
pro vyhledávání: '"Bilello JP"'
Autor:
Welch SR; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: swelch1@cdc.gov., Bilello JP; Gilead Sciences, Inc., Foster City, CA, USA., Carter K; Evotec US, Princeton, NJ, USA., Delang L; Virus-Host Interactions & Therapeutic Approaches Research Group, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium., Dirr L; Institute for Biomedicine and Glycomics, Griffith University, Southport, QLD, Australia., Durantel D; Centre International de Recherche en Infectiologie (CIRI), Inserm_U1111, CNRS_UMR5308, Université Claude Bernard Lyon 1, F-69007, Lyon, France., Feng JY; San Francisco, California, USA., Gowen BB; Institute for Antiviral Research and Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT, USA., Herrero LJ; Institute for Biomedicine and Glycomics, Griffith University, Southport, QLD, Australia., Janeba Z; Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nám. 2, 160 00 Prague, Czech Republic., Kleymann G; Innovative Molecules GmbH, Lipowsky Str. 10, 81373, Munich, Bavaria, Germany., Lee AA; PostEra Inc, 1 Broadway, Cambridge MA, USA., Meier C; Organic Chemistry, Department of Chemistry, Faculty of Sciences, University of Hamburg, Martin-Luther-King-Platz 6, Hamburg, Germany., Moffat J; Department of Microbiology & Immunology, SUNY Upstate Medical University, Syracuse, NY USA., Schang LM; Baker Institute and Department of Microbiology and Immunology, Cornell University, Ithaca, NY, USA., Schiffer JT; Fred Hutchinson Cancer Research Center, Vaccine and Infectious Diseases Division, Seattle, Washington, USA; Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA., Seley-Radtke KL; Department of Chemistry & Biochemistry, University of Maryland, Baltimore County, Baltimore, MD, USA., Sheahan TP; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, USA; Rapidly Emerging Antiviral Drug Development Initiative, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Spengler JR; Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: jspengler@cdc.gov.
Publikováno v:
Antiviral research [Antiviral Res] 2024 Nov 12, pp. 106037. Date of Electronic Publication: 2024 Nov 12.
Autor:
Citron MP; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States. Electronic address: michael_citron@merck.com., Zang X; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States., Leithead A; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States., Meng S; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States., Rose Ii WA; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States., Murray E; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States., Fontenot J; The University of Louisiana New Iberia Research Center, New Iberia, LA 70560, United States., Bilello JP; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States., Beshore DC; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States., Howe JA; Discovery, Preclinical and Translational Medicine, Merck & Co., Inc., Rahway, NJ, United States.
Publikováno v:
The Journal of infection [J Infect] 2024 Oct 23; Vol. 89 (6), pp. 106325. Date of Electronic Publication: 2024 Oct 23.
Autor:
Lin Y; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Virology, Antiviral Drug & Vaccine Research Group, Leuven, Belgium., Khan M; Max Planck Research Unit for Neurogenetics, Frankfurt, Germany., Weynand B; KU Leuven Department of Imaging and Pathology, Division of Translational Cell and Tissue Research, Leuven, Belgium., Laporte M; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Virology, Antiviral Drug & Vaccine Research Group, Leuven, Belgium., Coenjaerts F; Department of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Babusis D; Gilead Sciences Incorporated, Foster City, CA, USA., Bilello JP; Gilead Sciences Incorporated, Foster City, CA, USA., Mombaerts P; Max Planck Research Unit for Neurogenetics, Frankfurt, Germany., Jochmans D; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Virology, Antiviral Drug & Vaccine Research Group, Leuven, Belgium., Neyts J; KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Virology, Antiviral Drug & Vaccine Research Group, Leuven, Belgium. johan.neyts@kuleuven.be.; VirusBank Platform, KU Leuven, Leuven, Belgium. johan.neyts@kuleuven.be.
Publikováno v:
Nature communications [Nat Commun] 2024 Sep 05; Vol. 15 (1), pp. 7765. Date of Electronic Publication: 2024 Sep 05.
Autor:
Siegel DS; Gilead Sciences, Inc., Foster City, California 94404, United States., Hui HC; Gilead Sciences, Inc., Foster City, California 94404, United States., Pitts J; Gilead Sciences, Inc., Foster City, California 94404, United States., Vermillion MS; Gilead Sciences, Inc., Foster City, California 94404, United States.; Lovelace Biomedical, Albuquerque, New Mexico 87108, United States., Ishida K; Gilead Sciences, Inc., Foster City, California 94404, United States., Rautiola D; Gilead Sciences, Inc., Foster City, California 94404, United States., Keeney M; Gilead Sciences, Inc., Foster City, California 94404, United States., Irshad H; Lovelace Biomedical, Albuquerque, New Mexico 87108, United States., Zhang L; Gilead Sciences, Inc., Foster City, California 94404, United States., Chun K; Gilead Sciences, Inc., Foster City, California 94404, United States., Chin G; Gilead Sciences, Inc., Foster City, California 94404, United States., Goyal B; Gilead Sciences, Inc., Foster City, California 94404, United States., Doerffler E; Gilead Sciences, Inc., Foster City, California 94404, United States., Yang H; Gilead Sciences, Inc., Foster City, California 94404, United States., Clarke MO; Gilead Sciences, Inc., Foster City, California 94404, United States., Palmiotti C; Gilead Sciences, Inc., Foster City, California 94404, United States., Vijjapurapu A; Gilead Sciences, Inc., Foster City, California 94404, United States., Riola NC; Gilead Sciences, Inc., Foster City, California 94404, United States., Stray K; Gilead Sciences, Inc., Foster City, California 94404, United States., Murakami E; Gilead Sciences, Inc., Foster City, California 94404, United States., Ma B; Gilead Sciences, Inc., Foster City, California 94404, United States., Wang T; Gilead Sciences, Inc., Foster City, California 94404, United States., Zhao X; Gilead Sciences, Inc., Foster City, California 94404, United States., Xu Y; Gilead Sciences, Inc., Foster City, California 94404, United States., Lee G; Gilead Sciences, Inc., Foster City, California 94404, United States., Marchand B; Gilead Sciences, Inc., Foster City, California 94404, United States., Seung M; Gilead Sciences, Inc., Foster City, California 94404, United States., Nayak A; Gilead Sciences, Inc., Foster City, California 94404, United States., Tomkinson A; Gilead Sciences, Inc., Foster City, California 94404, United States., Kadrichu N; Inspired - Pulmonary Solutions, San Carlos, California 94070, United States., Ellis S; Gilead Sciences, Inc., Foster City, California 94404, United States., Barauskas O; Gilead Sciences, Inc., Foster City, California 94404, United States., Feng JY; Gilead Sciences, Inc., Foster City, California 94404, United States., Perry JK; Gilead Sciences, Inc., Foster City, California 94404, United States., Perron M; Gilead Sciences, Inc., Foster City, California 94404, United States., Bilello JP; Gilead Sciences, Inc., Foster City, California 94404, United States., Kuehl PJ; Lovelace Biomedical, Albuquerque, New Mexico 87108, United States., Subramanian R; Gilead Sciences, Inc., Foster City, California 94404, United States., Cihlar T; Gilead Sciences, Inc., Foster City, California 94404, United States., Mackman RL; Gilead Sciences, Inc., Foster City, California 94404, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2024 Aug 08; Vol. 67 (15), pp. 12945-12968. Date of Electronic Publication: 2024 Jul 17.
Autor:
Gordon CJ; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada., Walker SM; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada., Tchesnokov EP; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada., Kocincova D; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada., Pitts J; Gilead Sciences, Inc, Foster City, California, USA., Siegel DS; Gilead Sciences, Inc, Foster City, California, USA., Perry JK; Gilead Sciences, Inc, Foster City, California, USA., Feng JY; Gilead Sciences, Inc, Foster City, California, USA., Bilello JP; Gilead Sciences, Inc, Foster City, California, USA., Götte M; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada. Electronic address: gotte@ualberta.ca.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2024 Aug; Vol. 300 (8), pp. 107514. Date of Electronic Publication: 2024 Jun 28.
Autor:
Martinez DR; Department of Immunobiology, Yale School of Medicine, New Haven, CT 06510, USA.; Yale Center for Infection and Immunity, Yale School of Medicine, New Haven, CT 06510, USA., Moreira FR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Catanzaro NJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Diefenbacher MV; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Zweigart MR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Gully KL; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., De la Cruz G; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA., Brown AJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Adams LE; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Yount B; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Baric TJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Mallory ML; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Conrad H; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., May SR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Dong S; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Scobey DT; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Nguyen C; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Montgomery SA; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA., Perry JK; Gilead Sciences, Inc., Foster City, CA 94404, USA., Babusis D; Gilead Sciences, Inc., Foster City, CA 94404, USA., Barrett KT; Gilead Sciences, Inc., Foster City, CA 94404, USA., Nguyen AH; Gilead Sciences, Inc., Foster City, CA 94404, USA., Nguyen AQ; Gilead Sciences, Inc., Foster City, CA 94404, USA., Kalla R; Gilead Sciences, Inc., Foster City, CA 94404, USA., Bannister R; Gilead Sciences, Inc., Foster City, CA 94404, USA., Feng JY; Gilead Sciences, Inc., Foster City, CA 94404, USA., Cihlar T; Gilead Sciences, Inc., Foster City, CA 94404, USA., Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.; Rapidly Emerging Antiviral Drug Development Initiative, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Mackman RL; Gilead Sciences, Inc., Foster City, CA 94404, USA., Bilello JP; Gilead Sciences, Inc., Foster City, CA 94404, USA., Schäfer A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Rapidly Emerging Antiviral Drug Development Initiative, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Sheahan TP; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.; Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA.; Rapidly Emerging Antiviral Drug Development Initiative, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 May 22; Vol. 16 (748), pp. eadj4504. Date of Electronic Publication: 2024 May 22.
Autor:
Cross RW; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Woolsey C; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Chu VC; Gilead Sciences, Inc., Foster City, CA, USA., Babusis D; Gilead Sciences, Inc., Foster City, CA, USA., Bannister R; Gilead Sciences, Inc., Foster City, CA, USA., Vermillion MS; Gilead Sciences, Inc., Foster City, CA, USA., Geleziunas R; Gilead Sciences, Inc., Foster City, CA, USA., Barrett KT; Gilead Sciences, Inc., Foster City, CA, USA., Bunyan E; Gilead Sciences, Inc., Foster City, CA, USA., Nguyen AQ; Gilead Sciences, Inc., Foster City, CA, USA., Cihlar T; Gilead Sciences, Inc., Foster City, CA, USA., Porter DP; Gilead Sciences, Inc., Foster City, CA, USA., Prasad AN; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Deer DJ; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Borisevich V; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Agans KN; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Martinez J; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Harrison MB; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Dobias NS; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Fenton KA; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA., Bilello JP; Gilead Sciences, Inc., Foster City, CA, USA., Geisbert TW; Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Publikováno v:
Science (New York, N.Y.) [Science] 2024 Mar 15; Vol. 383 (6688), pp. eadk6176. Date of Electronic Publication: 2024 Mar 15.
Autor:
Mackman RL; Medicinal Chemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Kalla RV; Medicinal Chemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Babusis D; Drug Metabolism, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Pitts J; Discovery Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Barrett KT; Formulation and Process Development, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Chun K; Medicinal Chemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Du Pont V; Discovery Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Rodriguez L; Clinical Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Moshiri J; Clinical Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Xu Y; Biochemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Lee M; Biology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Lee G; Biology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Bleier B; Formulation and Process Development, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Nguyen AQ; Formulation and Process Development, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., O'Keefe BM; Process Chemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Ambrosi A; Process Chemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Cook M; Process Chemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Yu J; Process Chemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Dempah KE; Process Development, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Bunyan E; Process Development, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Riola NC; Discovery Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Lu X; Discovery Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Liu R; Drug Metabolism, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Davie A; Drug Metabolism, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Hsiang TY; Center for Innate Immunity and Immune Disease, Department of Immunology, School of Medicine, University of Washington, Seattle, Washington 98109 United States., Dearing J; Lovelace Biomedical Research Institute, 2425 Ridgecrest Drive Southeast, Albuquerque, New Mexico 87108 United States., Vermillion M; Lovelace Biomedical Research Institute, 2425 Ridgecrest Drive Southeast, Albuquerque, New Mexico 87108 United States., Gale M Jr; Center for Innate Immunity and Immune Disease, Department of Immunology, School of Medicine, University of Washington, Seattle, Washington 98109 United States., Niedziela-Majka A; Biology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Feng JY; Biochemistry, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Hedskog C; Clinical Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Bilello JP; Discovery Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Subramanian R; Drug Metabolism, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States., Cihlar T; Discovery Virology, Gilead Sciences Incorporated, 333 Lakeside Drive, Foster City, California 94404 United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2023 Sep 14; Vol. 66 (17), pp. 11701-11717. Date of Electronic Publication: 2023 Aug 19.
Autor:
Martinez DR; Department of Immunobiology, Yale School of Medicine, New Haven, CT, 06510, USA.; Yale Center for Infection and Immunity, Yale School of Medicine, New Haven, CT, 06510, USA., Moreira FR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Zweigart MR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Gully KL; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., De la Cruz G; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Brown AJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Adams LE; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Catanzaro N; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Yount B; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Baric TJ; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Mallory ML; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Conrad H; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., May SR; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Dong S; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Scobey DT; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Montgomery SA; Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA., Perry J; Gilead Sciences, Inc, Foster City, CA, USA., Babusis D; Gilead Sciences, Inc, Foster City, CA, USA., Barrett KT; Gilead Sciences, Inc, Foster City, CA, USA., Nguyen AH; Gilead Sciences, Inc, Foster City, CA, USA., Nguyen AQ; Gilead Sciences, Inc, Foster City, CA, USA., Kalla R; Gilead Sciences, Inc, Foster City, CA, USA., Bannister R; Gilead Sciences, Inc, Foster City, CA, USA., Bilello JP; Gilead Sciences, Inc, Foster City, CA, USA., Feng JY; Gilead Sciences, Inc, Foster City, CA, USA., Cihlar T; Gilead Sciences, Inc, Foster City, CA, USA., Baric RS; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Rapidly Emerging Antiviral Drug Development Initiative, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Mackman RL; Gilead Sciences, Inc, Foster City, CA, USA., Schäfer A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Rapidly Emerging Antiviral Drug Development Initiative, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Sheahan TP; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Rapidly Emerging Antiviral Drug Development Initiative, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Jun 28. Date of Electronic Publication: 2023 Jun 28.
Autor:
Radoshitzky SR; The Geneva Foundation, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA.; Division of Antivirals, Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA., Iversen P; The Geneva Foundation, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA., Lu X; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Zou J; Department of Biochemistry & Molecular Biology, Institute for Drug Discovery, Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA., Kaptein SJF; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, B-3000, Leuven, Belgium.; Global Virus Network, GVN, Baltimore, USA., Stuthman KS; The Geneva Foundation, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA., Van Tongeren SA; The Geneva Foundation, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA., Steffens J; The Geneva Foundation, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA., Gong R; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Truong H; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Sapre AA; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Yang H; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Xie X; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Chia JJ; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Song ZJ; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Leventhal SM; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Chan J; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Shornikov A; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Zhang X; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, B-3000, Leuven, Belgium.; Global Virus Network, GVN, Baltimore, USA., Cowfer D; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Yu H; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Warren T; The Geneva Foundation, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA.; Laulima Government Solutions, LLC., Orlando, FL, USA., Cihlar T; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Porter DP; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Neyts J; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, B-3000, Leuven, Belgium.; Global Virus Network, GVN, Baltimore, USA., Shi PY; Department of Biochemistry & Molecular Biology, Institute for Drug Discovery, Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA., Wells J; The Geneva Foundation, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA., Bilello JP; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA., Feng JY; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. joy.feng@gilead.com.
Publikováno v:
Scientific reports [Sci Rep] 2023 Feb 23; Vol. 13 (1), pp. 3131. Date of Electronic Publication: 2023 Feb 23.